News

Jot Dx™ Insertable Cardiac Monitor (ICM) expands Abbott's connected care portfolio and is the first and only device on the market with the option to control the amount of electronic data received for irregular heart rhythms, depending on the...

Kestra Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE® Wearable Cardioverter Defibrillator (WCD) system.

MindMics, Inc. reported results from the clinical trial at the Heart Rhythm Society meeting in Boston.

ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Board of Directors unanimously appointed Avi Fischer, M.D. as Chief Executive Officer (CEO) of the company and a member of its Board of Directors.

MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ – A new study to be presented this week at Heart Rhythm 2021 and recently published in the American Journal of Cardiology1 shows use of the KardiaMobile 6L device...

Solution provider showcases new AI-based products designed to eliminate key pain points of remote monitoring for cardiac practices, including disconnected patient management.

4-Dimension Imaging Helps Operators Better Understand Patient Anatomy

Patients experienced a normal sinus rate and improved quality of life compared to current treatment method.

First-Ever Economic Analysis of CABANA Trial Reveals Economic Benefits of Catheter Ablation Compared to Drug Therapy.

Results show ECG monitor is more than 200% more effective in detecting arrhythmias.